DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Aarti Pharmalabs Limited — Updates

NSE 1 hr ago·22 Sept 2026, 12:46 pm

Aarti Pharmalabs

Aarti Pharmalabs Limited has informed stock exchanges about a presentation made during its 7th Annual General Meeting (AGM). This update signals that the company is likely sharing its strategic outlook, financial performance, and future plans with its investors.

For investors, this is a routine corporate disclosure that provides transparency. It offers a glimpse into management's confidence and their roadmap for the company's growth. Staying informed about such updates helps investors align their expectations with the company's stated vision.

Investors should watch for specific details regarding the company's operational targets, expansion plans, and any guidance provided by the management during the presentation. These insights are crucial for assessing the company's long-term potential.